Malcolm Spicer, Managing Editor – US
Latest From Malcolm Spicer
CDER compliance office director Donald Ashley offers a cautionary note to temper expectations for the FDA’s enforcement in the supplement sector. “We continue to warn the public about products very often sold as dietary supplements that contain hidden drugs,” he says.
UCLA professor Chris Tang says like most US businesses relying on supplies or production from outside the country, particularly from China, consumer health and beauty and personal care product companies should expect at least another year of supply disruption.
Report by American Botanical Council from research by Nutrition Business Journal and SPINS shows sales of supplements with herbal and/or fungal ingredients increased a record 17.3% from 2019, the segment's first double-digit growth in at least 20 years.
Sale is among options it’s considering for materials business, which is currently “managed largely on a standalone basis.” Its health, nutrition and bioscience segments account for 80% to 85% of total sales and will operate as individual business groups.
Lowers Q3 net sales guidance to a decrease of 3.5% to 6.5% after previously forecasting a range between 5% growth and 1% decrease; for the year, it lowers previous estimate of 8.5% to 12.5% growth to net sales improving 4.5% to 8.5%.
Acting commissioner Woodcock reminds manufacturers and marketers that a consumer’s exposure to cannabidiol and other cannabinoids likely comes from using multiple products daily. “How do you control exposure of people in a nonprescription setting?”